1. Home
  2. NSPR vs DIT Comparison

NSPR vs DIT Comparison

Compare NSPR & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • DIT
  • Stock Information
  • Founded
  • NSPR 2005
  • DIT 1981
  • Country
  • NSPR United States
  • DIT United States
  • Employees
  • NSPR N/A
  • DIT N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • DIT Food Distributors
  • Sector
  • NSPR Health Care
  • DIT Consumer Discretionary
  • Exchange
  • NSPR Nasdaq
  • DIT Nasdaq
  • Market Cap
  • NSPR 101.8M
  • DIT 70.4M
  • IPO Year
  • NSPR N/A
  • DIT 1995
  • Fundamental
  • Price
  • NSPR $2.38
  • DIT $119.30
  • Analyst Decision
  • NSPR Strong Buy
  • DIT
  • Analyst Count
  • NSPR 2
  • DIT 0
  • Target Price
  • NSPR $4.50
  • DIT N/A
  • AVG Volume (30 Days)
  • NSPR 78.3K
  • DIT 411.0
  • Earning Date
  • NSPR 11-11-2025
  • DIT 11-07-2025
  • Dividend Yield
  • NSPR N/A
  • DIT 0.84%
  • EPS Growth
  • NSPR N/A
  • DIT N/A
  • EPS
  • NSPR N/A
  • DIT 2.14
  • Revenue
  • NSPR $7,066,000.00
  • DIT $2,251,684,195.00
  • Revenue This Year
  • NSPR $7.48
  • DIT N/A
  • Revenue Next Year
  • NSPR $104.39
  • DIT N/A
  • P/E Ratio
  • NSPR N/A
  • DIT $56.28
  • Revenue Growth
  • NSPR 7.60
  • DIT 7.64
  • 52 Week Low
  • NSPR $1.99
  • DIT $94.92
  • 52 Week High
  • NSPR $3.80
  • DIT $163.75
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 44.77
  • DIT 56.80
  • Support Level
  • NSPR $2.35
  • DIT $117.50
  • Resistance Level
  • NSPR $2.45
  • DIT $121.00
  • Average True Range (ATR)
  • NSPR 0.08
  • DIT 2.45
  • MACD
  • NSPR -0.00
  • DIT 0.33
  • Stochastic Oscillator
  • NSPR 23.53
  • DIT 82.72

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About DIT AMCON Distributing Company

Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.

Share on Social Networks: